Alopecia Treatment Market, By Drug Class, By Disease Type, By Route of Administration, By Distribution Channel, By geography

Description

Alopecia Treatment Market is estimated to be valued at USD 11.38 Bn in 2026 and is expected to reach USD 16.89 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 11.38 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.80%	2033 Value Projection:	USD 16.89 Bn

Alopecia is the medical term for hair loss. Hair loss can happen naturally or as a result of a disease or the use of certain medications. Some common types of alopecia include

Androgenic alopecia is common in both men and women. It is also referred to as male- or female-pattern hair loss.
Alopecia areata- Alopecia areata is also known as patchy baldness. Bald patches can appear anywhere on the body, but the majority of people get a round or oval patch on the scalp.
Traction alopecia is caused by putting stress on the hair by pulling or stretching it repeatedly

Market Dynamics

Market players are focused on product launches or approvals, which is expected to drive growth of the global alopecia treatment market over the forecast period. For instance, in September 2022, Dr. Reddy's Laboratories Limited announced the launch of Minoxidil topical solution USP 2% and 5% for the treatment of female pattern hair loss (FPHL). Dr. Reddy's will market its products as Mintop 2 percent and Mintop Eva 5 percent, respectively. The launch comes after the Central Drugs Standard Control Organization (CDSCO) in India approved the use of Minoxidil topical solution USP 2% and 5% for the treatment of FPHL for the first time.

Market players are focused on inorganic strategies such as acquisitions, partnerships, and agreements with other market players. This is expected to drive the market growth over the forecast period. For instance, in August 2017, Aclaris Therapeutics, Inc., a biopharmaceutical company based in the U.S. acquired Confluence Life Sciences, Inc., which expanded Aclaris' inflammation and immunology pipeline with the addition of Confluence's lead product candidates CDD-450, topical Janus kinase inhibitors, and IL2-inducible T-cell kinase inhibitor programs.

Moreover, market players are focused on research and development activities is expected to propel the growth of the global alopecia treatment market. For instance, in August 2022, Pfizer Inc., a multinational biopharmaceutical company announced positive top-line results from the Phase 2b/3 ALLEGRO trial, which evaluated oral once-daily ritlecitinib in patients with alopecia areata, an autoimmune disease characterized by an immune attack on hair follicles that causes hair loss on the scalp and can also affect the face and body.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players.
It profiles leading players in the global alopecia treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
Key companies covered as a part of this study include Aclaris Therapeutics, Inc., Fagron, Follicum AB, Cipla Inc., Arcutis Biotherapeutics, Dr. Reddy's Laboratories Ltd., Himalaya Wellness Company, Eli Lilly and Company, Concert Pharmaceuticals Inc., and Teva Pharmaceutical Industries Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics.
The global alopecia treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global alopecia treatment market.

Market Segmentation

By Drug Class (Revenue, USD Bn, 2021 - 2033)
Corticosteroids
5 AR Inhibitors
Vasodilators
Others
By Disease Type (Revenue, USD Bn, 2021 - 2033)
Alopecia Areata
Androgenic Alopecia
Traction Alopecia
Others
By Route of Administration (Revenue, USD Bn, 2021 - 2033)
Topical
Oral
Injectable
By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Geography (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Stemson Therapeutics
OliX Pharmaceuticals, Inc.
Pfizer Inc.
Aclaris Therapeutics, Inc.
Fagron, Follicum AB
Cipla Inc.
Arcutis Biotherapeutics
Reddy's Laboratories Ltd.
Himalaya Wellness Company
Cosmo Pharmaceuticals N.V.
Equillium, Inc.
Eli Lilly and Company
Concert PharmaceuticIals Inc.
Teva Pharmaceutical Industries Ltd.

Product Code: CMI1847

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Disease Type
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Recent Trends
Mergers, Acquisitions, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
PORTER's Analysis

4. Global Alopecia Treatment Market, By Drug Class, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
5 AR Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
Vasodilators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends

5. Global Alopecia Treatment Market, By Disease Type, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Alopecia Areata
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
Androgenic Alopecia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
Traction Alopecia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends

6. Global Alopecia Treatment Market, By Route of Administration, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends
Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Segment Trends

7. Global Alopecia Treatment Market, By Distribution Channel, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Alopecia Treatment Market, By Region, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
North America
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.S.
  - Canada
Europe
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 -2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021 - 2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Stemson Therapeutics
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- OliX Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Pfizer Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Aclaris Therapeutics
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Fagron,
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Follicum AB
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Cipla Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Arcutis Biotherapeutics
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Dr. Reddy's Laboratories Ltd.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Himalaya Wellness Company
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Cosmo Pharmaceuticals N.V.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Equillium, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Eli Lilly and Company
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Concert Pharmaceuticals Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
Analysts' Views

10. Section

References
Research Methodology
About Us and Sales Contact